Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-18T23:12:38.439Z Has data issue: false hasContentIssue false
  • English
  • Français

A comparison between bispectral index analysis and auditory-evoked potentials for monitoring the time to peak effect to calculate the plasma effect site equilibration rate constant of propofol

Published online by Cambridge University Press:  01 October 2007

M.-Z. Zhang ,
Q. Yu ,
Y.-L. Huang ,
S.-J. Wang  and
X.-R. Wang
M.-Z. Zhang*
Affiliation:
Shanghai Jiao Tong University School of Medicine, Renji Hospital, Department of Anaesthesiology, Shanghai, China
Q. Yu
Affiliation:
Shanghai Jiao Tong University School of Medicine, Renji Hospital, Department of Anaesthesiology, Shanghai, China
Y.-L. Huang
Affiliation:
Shanghai Jiao Tong University School of Medicine, Renji Hospital, Department of Anaesthesiology, Shanghai, China
S.-J. Wang
Affiliation:
Shanghai Jiao Tong University School of Medicine, Renji Hospital, Department of Anaesthesiology, Shanghai, China
X.-R. Wang
Affiliation:
Shanghai Jiao Tong University School of Medicine, Renji Hospital, Department of Anaesthesiology, Shanghai, China
*
Correspondence to: Ma-Zhong Zhang, Department of Anaesthesiology, Shanghai Renji Hospital, 145 # Shandong (C) Road, Shanghai, 200001, China. E-mail: [email protected]; Tel: +86 21 13601604170; Fax: +8621 50903239
Get access

Summary

Background and objectives

To the best of our knowledge, the value of the plasma effect site equilibration rate constant (ke0) of propofol has not been reported in Chinese patients. The aim of this prospective, randomized study was to examine the characteristics of the time to peak effect (TPEAK) of propofol, a pharmacokinetic-independent descriptor of blood–brain equilibration, and ke0 derived from TPEAK with A-line auditory-evoked potential monitor and Aspect A-2000 bispectral index monitor in Chinese patients.

Methods

Two-hundred ASA I patients received a submaximal bolus dose of propofol (1.5 mg kg−1). TPEAK was randomly measured by means of the A-line auditory-evoked potential monitor (Group AAI (auditory-evoked potential index), n = 100) or the Aspect A-2000 bispectral index monitor (Group BIS, n = 100). Using TPEAK and four previously validated pharmacokinetic parameter sets of propofol, the ke0 was estimated according to a method proposed recently.

Results

The mean TPEAK was 145 ± 35 s (50–224 s) and 74±24 s (38–143 s) in Groups AAI and BIS, respectively (P < 0.01 between groups). There were no correlations between the patient’s age and TPEAKs (r = 0.147 and 0.031 for Groups AAI and BIS). The median ke0 in Group AAI was 0.64 min−1 with the model of Marsh, 0.17 min−1 with the Schnider model, 0.78 min−1 with the Tackley model and 0.93 min−1 with the Shafer model. The median ke0 in Group BIS was 1.87 min−1 with the model of Marsh, 0.83 min−1 with the Schnider model, 2.14 min−1 with the Tackley model and 2.48 min−1 with the Shafer model (P < 0.01 between groups and models).

Conclusions

The TPEAK of propofol measured by the A-line auditory-evoked potential monitor is different from that measured by the Aspect A-2000 bispectral index monitor. The TPEAKs of propofol from auditory-evoked potential index and bispectral index, and the values of ke0 calculated based on TPEAKs are different from previous reports and appear to be not affected by age. Further studies need to be taken to validate clinically the ke0 values of propofol.

Keywords

ANAESTHETICS, intravenousPROPOFOLMONITORING PHYSIOLOGIC, bispectral index, auditory evoked potentialsPHARMACOLOGYPHARMACOKINETICS
Type
Original Article
Information
European Journal of Anaesthesiology , Volume 24 , Issue 10 , October 2007 , pp. 876 - 881
Copyright
Copyright © European Society of Anaesthesiology 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Egan, TD. Target-controlled drug delivery: progress toward an intravenous ‘vaporizer’ and automated anesthetic administration. Anesthesiology 2003; 99: 1214–1219.CrossRefGoogle ScholarPubMed
2.Shafer, SL, Gregg, KM. Algorithms to rapidly achieve and maintain stable drug concentration at the site of drug effect with a computer-controlled infusion pump. J Pharmacokinet Biopharmaceut 1992; 20: 147–169.CrossRefGoogle ScholarPubMed
3.Minto, CF, Schnider, TW, Gregg, KM et al. . Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics. Anesthesiology 2003; 99: 324–333.CrossRefGoogle ScholarPubMed
4.Muñoz, HR, Cortínez, LI, Ibacache, ME et al. . Estimation of the plasma effect equilibration rate constant (k e0) of propofol in children using the time to peak effect. Anesthesiology 2004; 101: 1269–1274.CrossRefGoogle ScholarPubMed
5.Kazama, T, Ikeda, K, Morita, K et al. . Comparison of the effect-site k e0s of propofol for blood pressure and EEG bispectral index in elderly and younger patients. Anesthesiology 1999; 90: 1517–1527.CrossRefGoogle Scholar
6.Marsh, B, White, M, Morton, N et al. . Pharmacokinetic model driven infusion of propofol in children. Br J Anaesth 1991; 67: 41–48.CrossRefGoogle ScholarPubMed
7.Schnider, TW, Minto, CF, Gambus, PL et al. . The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998; 88: 1170–1182.CrossRefGoogle ScholarPubMed
8.Tackley, RM, Lewis, GTR, Prys-Roberts, C et al. . Computer controlled infusion of propofol. Br J Anaesth 1989; 62: 46–53.CrossRefGoogle ScholarPubMed
9.Shafer, AS, Doze, VA, Shafer, SL et al. . Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia. Anesthesiology 1988; 69: 348–356.CrossRefGoogle ScholarPubMed
10.Schnider, TW, Minto, CF, Shafer, SL et al. . The influence of age on propofol pharmacodynamics. Anesthesiology 1999; 90: 1502–1516.CrossRefGoogle ScholarPubMed
11.Flaishon, R, Windsor, A, Sigl, J et al. . Recovery of consciousness after thiopental or propofol. Bispectral index and isolated forearm technique. Anesthesiology 1997; 86: 613–619.CrossRefGoogle ScholarPubMed
12.Zhang, MZ, Wu, J, Wang, SJ et al. . The application and evaluation of target-controlled infusion propofol. CJA 2002; 22: 660–663 (in Chinese).Google Scholar
13.Zheng, H, Cao, XH, Wang, J et al. . The difference of target-controlled and measured propofol concentration. CJA 2003; 23: 822–825 (in Chinese).Google Scholar
14.Youngs, EJShafer, SL. Basic pharmacokinetic and phaemacodynamic principles. In: White PF, ed. Textbook of intravenous anesthesia. Baltimore, USA: Williams & Wilkins Inc, 1997: 10–26.Google Scholar
15.Ludbrook, GL, Visco, E, Lam, AM. Propofol: relations between brain concentrations, electroencephalogram, middle cerebral artery blood flow velocity, and cerebral oxygen extraction during induction of anesthesia. Anesthesiology 2002; 97: 1363–1370.CrossRefGoogle ScholarPubMed
16.Critchley, JA, Nimmo, GR, Gregson, CA et al. . Intersubject and ethnic differences in paracetamol metabolism. Br J Clin Pharmacol 1986; 22: 647–657.CrossRefGoogle ScholarPubMed
17.Iron, A, Groppi, A, Flery, B et al. . Polymorphism of class I alcohol-dehydrogenase in French, Vietnamese and Niger populations: genotyping by PCR amplification and RFLP analysis of dried blood spot. Ann Genet 1992; 25: 152–156.Google Scholar
18.Ortolani, O, Conti, A, Sall-Ka, B et al. . The recovery of Senegalese African blacks from intravenous anesthesia with propofol and remifentanil is slower than that of Caucasians. Anesth Analg 2001; 93: 1222–1226.CrossRefGoogle ScholarPubMed
19.Krejcie, TC, Avram, MJ. What determines anesthetic induction dose? It’s the front-end kinetic, doctor! Anesth Analg 1999; 89: 541–544.Google ScholarPubMed
20.Litvan, H, Jensen, EW, Revuelta, M et al. . Comparison of auditory evoked potentials and the A-line ARX index for monitoring the hypnotic level during sevoflurane and propofol induction. Acta Anaesthesiol Scand 2002; 46: 245–251.CrossRefGoogle ScholarPubMed
21.Gajraj, RJ, Doi, M, Mantzaridis, H et al. . Analysis of the EEG bispectrum, auditory evoked potentials and the EEG power spectrum during repeated transitions from consciousness to unconsciousness. Br J Anaesth 1998; 80: 46–52.CrossRefGoogle ScholarPubMed
22.Glass, PS, Bloom, M, Kearse, L et al. . Bispectral analysis measures sedation and memory effects of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology 1997; 86: 836–847.CrossRefGoogle ScholarPubMed
23.Iselin-Chaves, IA, Moalem, HEEI, Gan, TJ et al. . Changes in the auditory evoked potentials and the bispectral index following propofol or propofol and alfentanil. Anesthesiology 2000; 92: 1300–1310.CrossRefGoogle ScholarPubMed
24.Leslie, K, Sessler, D, Schroeder, M et al. . Propofol blood concentration and bispectral index predict suppression of learning during propofol/epidural anesthesia in volunteers. Anesth Analg 1995; 81: 1269–1274.Google ScholarPubMed
25.Gajraj, RJ, Doi, M, Mantzaridis, H et al. . Comparison of bispectral EEG analysis and auditory evoked potentials for monitoring depth of anaesthesia during propofol anaesthesia. Br J Anaesth 1999; 82: 672–678.CrossRefGoogle ScholarPubMed
26.Wakeling, HG, Zimmerman, JB, Howell, S et al. . Targeting effect compartment or central compartment concentration: what predicts loss of consciousness? Anesthesiology 1999; 90: 92–97.CrossRefGoogle ScholarPubMed